Complete Filing Data
Summit Therapeutics Inc. reported Stockholders Equity of $658.86 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Summit Therapeutics Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.08B | -$221.3M | -$614.9M | -$78.8M | -$88.6M | -$52.7M | -$29.1M | -$20.2M | -$21.4M | -$20.1M |
| Research And Development Expense | $59.5M | $52.0M | $85.4M | $53.3M | $39.8M | $29.0M | $19.0M | $16.9M | ||
| Operating Expenses | $1.09B | $226.0M | $609.7M | $87.2M | $109.0M | $73.4M | $51.1M | |||
| General And Administrative Expense | $556.8M | $60.2M | $29.3M | $26.7M | $23.6M | $19.2M | $11.3M | |||
| Comprehensive Income Net Of Tax | -$1.08B | -$221.2M | -$615.5M | -$78.5M | -$87.0M | -$51.7M | -$29.1M | |||
| Nonoperating Income Expense | $14.8M | $13.4M | $11.2M | -$2.3M | -$2.4M | $283.0K | -$1.6M | |||
| Operating Income Loss | -$226.0M | -$609.7M | -$72.1M | -$86.2M | -$53.2M | -$27.5M | ||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $705.0K | $1.8M | $860.0K | $743.0K | ||||
| Amortization Of Intangible Assets | $0.00 | $0.00 | $914.0K | $1.0M | $1.3M | $970.0K | ||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $304.0K | $1.6M | $970.0K | $51.0K | ||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$327.0K | $60.0K | -$172.0K | $304.0K | ||||||
| Income Taxes Paid Net | $0.00 | $0.00 | $52.0K | $0.00 | $7.0K | -$70.0K | $63.0K | |||
| Research And Development Tax Credit Receivable Current | $557.0K | $848.0K | $5.8M | $15.7M | $9.9M | |||||
| Interest Expense Income Noncash | $0.00 | $0.00 | $6.3M | $4.3M | $196.0K | $255.0K | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$614.9M | -$78.8M | -$88.6M | -$52.9M | -$29.1M | |||||
| Cumulative Currency Translation Gains Losses Realized Upon Sale Or Liquidation Reclassified From Other Comprehensive Income | $0.00 | $0.00 | $419.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$231.8M | -$565.7M | -$62.9M | -$56.3M | -$60.4M | -$43.5M | -$21.3M | -$14.7M | -$542.4M | -$21.4M | -$16.8M | -$21.4M | -$19.6M | -$24.4M | -$17.5M | -$17.7M | -$15.3M | -$6.1M | -$6.4M |
| Research And Development Expense | $30.9M | $15.3M | $9.5M | $9.9M | $17.0M | $9.0M | $20.6M | $19.9M | $23.9M | $18.4M | $13.7M | $13.6M | $12.9M | $10.0M | |||||
| Operating Expenses | $234.2M | $568.4M | $66.9M | $58.4M | $59.6M | $42.4M | $20.8M | $15.8M | $537.7M | $22.6M | $15.9M | $27.2M | $25.6M | $29.9M | $22.6M | $21.4M | $19.3M | $16.5M | $12.6M |
| General And Administrative Expense | $103.1M | $360.4M | $15.6M | $20.7M | $13.8M | $11.5M | $5.4M | $6.3M | $6.9M | $5.6M | $6.9M | $6.7M | $5.7M | $6.0M | $4.2M | $6.8M | $5.8M | $3.6M | $2.7M |
| Comprehensive Income Net Of Tax | -$231.8M | -$565.9M | -$63.2M | -$56.1M | -$60.3M | -$43.5M | -$21.2M | -$15.8M | -$541.9M | -$21.4M | -$16.0M | -$23.2M | -$20.5M | -$23.9M | -$16.8M | -$15.4M | -$15.3M | -$10.8M | -$7.6M |
| Nonoperating Income Expense | $2.4M | $2.7M | $3.9M | $4.6M | $2.3M | $2.0M | -$776.0K | $1.1M | -$5.2M | -$4.4M | -$4.1M | $761.0K | -$113.0K | -$686.0K | -$565.0K | -$858.0K | -$114.0K | $3.3M | |
| Operating Income Loss | -$58.4M | -$59.6M | -$42.4M | -$20.5M | -$15.8M | -$537.2M | -$16.9M | -$12.7M | -$22.2M | -$19.5M | -$23.7M | -$16.9M | -$16.9M | -$15.4M | -$9.3M | -$6.2M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $0.00 | $220.0K | $235.0K | $250.0K | $1.3M | $57.0K | $192.0K | $181.0K | $170.0K | $324.0K | $148.0K | |||||
| Amortization Of Intangible Assets | $0.00 | $0.00 | $0.00 | $217.0K | $232.0K | $248.0K | $256.0K | $257.0K | $255.0K | $266.0K | |||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$49.0K | $789.0K | -$1.8M | -$863.0K | $540.0K | $675.0K | $2.3M | -$52.0K | -$4.6M | -$1.3M | |||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $43.0K | -$189.0K | -$145.0K | -$155.0K | $92.0K | -$12.0K | $108.0K | -$76.0K | -$51.0K | -$49.0K | $789.0K | -$1.8M | |||||||
| Income Taxes Paid Net | $0.00 | $6.0K | |||||||||||||||||
| Research And Development Tax Credit Receivable Current | $660.0K | $953.0K | $945.0K | $812.0K | $4.6M | $4.5M | $13.0M | $14.1M | $15.3M | $10.1M | $10.4M | $13.6M | |||||||
| Interest Expense Income Noncash | $0.00 | $6.1M | $198.0K | $103.0K | |||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$19.6M | -$24.4M | -$17.5M | -$17.8M | -$15.5M | -$6.1M | -$6.3M | ||||||||||||
| Cumulative Currency Translation Gains Losses Realized Upon Sale Or Liquidation Reclassified From Other Comprehensive Income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $419.0K | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $658.9M | $388.7M | $77.7M | $126.7M | $83.3M | $79.5M | $78.9M | -$3.6M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $225.6M | $105.2M | $71.4M | $648.6M | $71.8M | $66.4M | $63.8M | $28.5M | |||
| Goodwill | $2.0M | $1.9M | $1.9M | $1.8M | $2.0M | $2.0M | $2.0M | $2.5M | $664.0K | ||
| Liabilities | $92.3M | $46.8M | $125.3M | $537.5M | $30.1M | $23.0M | $17.4M | $58.3M | $41.1M | ||
| Assets | $751.2M | $435.6M | $202.9M | $664.2M | $113.4M | $102.5M | $96.2M | $55.2M | $37.6M | ||
| Retained Earnings Accumulated Deficit | -$2.29B | -$1.21B | -$993.3M | -$378.3M | -$299.5M | -$210.9M | -$158.2M | ||||
| Property Plant And Equipment Net | $1.1M | $254.0K | $204.0K | $906.0K | $694.0K | $725.0K | $518.0K | ||||
| Other Liabilities Noncurrent | $1.8M | $1.6M | $1.6M | $1.4M | $2.8M | $2.5M | $2.7M | ||||
| Other Liabilities Current | $2.3M | $1.8M | $717.0K | $662.0K | $897.0K | $729.0K | $366.0K | ||||
| Operating Lease Right Of Use Asset | $20.6M | $7.1M | $5.9M | $4.2M | $2.8M | $554.0K | $1.0M | ||||
| Operating Lease Liability Noncurrent | $17.5M | $3.5M | $3.3M | $2.8M | $1.7M | $75.0K | $422.0K | ||||
| Operating Lease Liability Current | $3.4M | $3.8M | $2.8M | $1.7M | $1.1M | $390.0K | $471.0K | ||||
| Liabilities Current | $73.0M | $41.7M | $20.4M | $38.8M | $25.6M | $19.9M | $13.8M | ||||
| Liabilities And Stockholders Equity | $751.2M | $435.6M | $202.9M | $664.2M | $113.4M | $102.5M | $96.2M | ||||
| Common Stock Value | $7.8M | $7.4M | $7.0M | $2.1M | $980.0K | $826.0K | $672.0K | ||||
| Assets Current | $720.3M | $423.8M | $189.7M | $656.7M | $97.3M | $87.7M | $79.6M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.5M | -$2.3M | -$2.4M | -$1.9M | -$2.2M | -$3.8M | -$4.8M | ||||
| Accrued Liabilities Current | $32.1M | $19.6M | $8.8M | $10.7M | $7.2M | $3.3M | $5.7M | ||||
| Accounts Payable Current | $20.3M | $4.6M | $2.7M | $355.0K | $4.4M | $6.1M | $4.5M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $120.4M | $33.8M | -$577.2M | $576.8M | $5.4M | $2.6M | $28.6M | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $17.1M | $4.2M | $4.2M | $2.9M | $3.4M | $0.00 | |||||
| Cash And Cash Equivalents At Carrying Value | $225.3M | $104.9M | $71.4M | $348.6M | $71.8M | $63.8M | |||||
| Repayments Of Related Party Debt | $0.00 | $100.0M | $24.7M | $25.0M | $110.0M | $0.00 | |||||
| Equity | $658.9M | $388.7M | $77.7M | $126.7M | $83.3M | $79.5M | $78.9M | -$3.6M | |||
| Cash And Cash Equivalents | $48.4M | $20.1M | $28.1M | $16.3M | $11.3M | ||||||
| Other Assets Noncurrent | $7.2M | $2.5M | $4.3M | $577.0K | $170.0K | $0.00 | |||||
| Operating Lease Right Of Use Asset Amortization Expense | $1.9M | $1.3M | $1.1M | $451.0K | $347.0K | ||||||
| Employee Related Liabilities Current | $14.9M | $12.0M | $5.4M | $5.6M | $4.1M | $983.0K | |||||
| Restricted Cash Current | $316.0K | $325.0K | $0.00 | $300.0M | $0.00 | ||||||
| Other Assets Current | $181.0K | $486.0K | $1.2M | $1.5M | $1.4M | ||||||
| Accounts Receivable Net Current | $0.00 | $349.0K | $1.5M | $331.0K | $541.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $192.3M | $259.4M | $344.3M | $437.9M | $195.1M | $44.2M | $99.4M | $119.6M | $133.5M | $133.2M | $51.3M | $64.4M | $102.3M | $119.4M | $64.4M | $38.5M | $53.6M | $68.4M | $36.2M | $43.6M | $32.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $238.9M | $298.2M | $211.8M | $94.1M | $28.8M | $61.6M | $23.8M | $42.1M | $71.0M | $122.0M | $57.3M | $77.5M | $80.2M | $103.4M | $102.2M | $21.3M | $36.4M | $54.9M | $21.6M | $12.1M | |||
| Goodwill | $2.0M | $2.0M | $1.9M | $2.0M | $1.9M | $1.9M | $1.8M | $1.9M | $1.8M | $1.7M | $1.8M | $2.0M | $2.0M | $2.1M | $2.0M | $2.3M | |||||||
| Liabilities | $69.5M | $64.6M | $39.5M | $64.9M | $146.8M | $132.6M | $119.1M | $117.8M | $121.4M | $22.1M | $44.4M | $52.1M | $26.4M | $26.1M | $76.4M | $20.0M | |||||||
| Assets | $261.7M | $324.0M | $383.8M | $502.9M | $341.9M | $176.8M | $218.5M | $237.4M | $254.9M | $155.3M | $95.7M | $116.5M | $128.7M | $145.5M | $140.8M | $56.9M | |||||||
| Retained Earnings Accumulated Deficit | -$2.07B | -$1.84B | -$1.28B | -$1.15B | -$1.10B | -$1.04B | -$956.7M | -$935.4M | -$920.7M | -$359.1M | -$337.7M | -$320.9M | -$272.4M | -$252.9M | -$228.4M | -$199.2M | |||||||
| Property Plant And Equipment Net | $810.0K | $690.0K | $652.0K | $265.0K | $223.0K | $181.0K | $229.0K | $225.0K | $412.0K | $930.0K | $1.1M | $965.0K | $656.0K | $757.0K | $684.0K | $724.0K | |||||||
| Other Liabilities Noncurrent | $1.8M | $1.8M | $1.7M | $1.7M | $1.6M | $3.3M | $1.5M | $1.5M | $1.5M | $2.4M | $2.6M | $2.8M | $2.7M | $2.7M | $2.6M | $2.3M | |||||||
| Other Liabilities Current | $2.0M | $1.5M | $759.0K | $1.0M | $806.0K | $788.0K | $484.0K | $619.0K | $320.0K | $209.0K | $265.0K | $678.0K | $1.0M | $661.0K | $581.0K | $354.0K | |||||||
| Operating Lease Right Of Use Asset | $5.4M | $5.6M | $6.4M | $8.0M | $8.7M | $9.4M | $6.4M | $7.0M | $3.9M | $4.2M | $2.0M | $2.4M | $1.9M | $2.2M | $1.5M | $628.0K | |||||||
| Operating Lease Liability Noncurrent | $2.7M | $2.4M | $2.9M | $4.2M | $5.0M | $5.8M | $3.9M | $4.3M | $2.5M | $3.0M | $1.3M | $1.5M | $896.0K | $1.1M | $351.0K | $162.0K | |||||||
| Operating Lease Liability Current | $2.7M | $3.1M | $3.5M | $3.8M | $3.7M | $3.7M | $2.8M | $2.9M | $1.7M | $1.4M | $684.0K | $907.0K | $941.0K | $1.0M | $1.1M | $386.0K | |||||||
| Liabilities Current | $64.9M | $60.3M | $34.9M | $59.0M | $140.2M | $23.4M | $113.7M | $11.9M | $17.4M | $16.7M | $15.2M | $22.7M | $22.8M | $21.9M | $73.1M | $14.7M | |||||||
| Liabilities And Stockholders Equity | $261.7M | $324.0M | $383.8M | $502.9M | $341.9M | $176.8M | $218.5M | $237.4M | $254.9M | $155.3M | $95.7M | $116.5M | $128.7M | $145.5M | $140.8M | $56.9M | |||||||
| Common Stock Value | $7.4M | $7.4M | $7.4M | $7.4M | $7.2M | $7.0M | $7.0M | $7.0M | $7.0M | $2.0M | $981.0K | $981.0K | $976.0K | $974.0K | $829.0K | $672.0K | |||||||
| Assets Current | $246.5M | $309.2M | $370.8M | $490.3M | $328.8M | $163.3M | $205.0M | $227.5M | $248.0M | $137.1M | $79.4M | $99.4M | $102.2M | $121.5M | $125.2M | $42.1M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.7M | -$2.8M | -$2.6M | -$2.3M | -$2.5M | -$2.4M | -$2.3M | -$2.4M | -$1.4M | -$3.2M | -$3.2M | -$4.0M | -$3.4M | -$2.6M | -$3.1M | -$7.0M | |||||||
| Accrued Liabilities Current | $27.0M | $26.1M | $21.2M | $18.5M | $12.5M | $6.5M | $3.7M | $3.9M | $12.3M | $11.1M | $5.5M | $7.6M | $7.4M | $6.1M | $4.9M | $4.4M | |||||||
| Accounts Payable Current | $22.2M | $23.0M | $5.0M | $3.3M | $3.3M | $6.4M | $3.3M | $987.0K | $710.0K | $1.4M | $3.6M | $7.0M | $5.9M | $6.9M | $4.1M | $2.5M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $106.7M | -$9.8M | -$577.6M | $5.7M | $35.8M | -$8.9M | |||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $4.2M | $0.00 | $2.8M | $0.00 | $0.00 | $1.1M | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $238.6M | $297.9M | $211.5M | $93.8M | $28.4M | $61.3M | $23.8M | $42.1M | $71.0M | $122.0M | $103.4M | $102.2M | $66.4M | $21.3M | |||||||||
| Repayments Of Related Party Debt | $75.5M | $0.00 | $24.7M | $0.00 | |||||||||||||||||||
| Equity | $192.3M | $259.4M | $344.3M | $437.9M | $195.1M | $44.2M | $99.4M | $119.6M | $133.5M | $133.2M | $51.3M | $64.4M | $102.3M | $119.4M | $64.4M | $38.5M | $53.6M | $68.4M | $36.2M | $43.6M | $32.2M | ||
| Cash And Cash Equivalents | |||||||||||||||||||||||
| Other Assets Noncurrent | $7.0M | $6.5M | $4.1M | $1.9M | $1.9M | $1.9M | $4.3M | $254.0K | $156.0K | $140.0K | $179.0K | $166.0K | |||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $285.0K | $298.0K | $152.0K | $112.0K | |||||||||||||||||||
| Employee Related Liabilities Current | $11.0M | $6.6M | $4.4M | $8.0M | $4.9M | $6.0M | $3.5M | $3.5M | $2.4M | $2.5M | $1.9M | $1.5M | |||||||||||
| Restricted Cash Current | $321.0K | $319.0K | $318.0K | $323.0K | $320.0K | $317.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Other Assets Current | $120.0K | $1.8M | $409.0K | $428.0K | $2.3M | $1.5M | $1.2M | $963.0K | $985.0K | $1.7M | |||||||||||||
| Accounts Receivable Net Current | $0.00 | $0.00 | $0.00 | $140.0K | $238.0K | $870.0K | $2.3M | $1.1M | $447.0K | $4.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $732.4M | $51.0M | $14.1M | $11.9M | $12.8M | $1.8M | $845.0K |
| Payments To Acquire Property Plant And Equipment | $657.0K | $139.0K | $128.0K | $624.0K | $306.0K | $421.0K | $205.0K |
| Net Cash Provided By Used In Operating Activities | -$322.9M | -$142.1M | -$76.8M | -$41.6M | -$72.6M | -$48.1M | -$20.8M |
| Net Cash Provided By Used In Investing Activities | -$174.3M | -$205.3M | -$587.8M | -$624.0K | -$306.0K | -$421.0K | -$341.0K |
| Net Cash Provided By Used In Financing Activities | $617.5M | $381.2M | $86.5M | $620.2M | $77.9M | $50.6M | $49.5M |
| Increase Decrease In Accounts Payable | $15.3M | $2.0M | $2.3M | -$4.1M | -$1.7M | $1.6M | -$1.3M |
| Increase Decrease In Accrued Liabilities | $12.9M | $11.9M | -$2.4M | $4.8M | $5.1M | -$1.3M | -$51.0K |
| Increase Decrease In Accounts Receivable | $0.00 | -$359.0K | -$975.0K | $1.1M | -$212.0K | -$5.4M | |
| Stock Issued During Period Value Share Based Compensation | $13.0M | $3.3M | $929.0K | $399.0K | $3.1M | ||
| Increase Decrease In Operating Lease Liability | -$167.0K | -$359.0K | $152.0K | -$1.1M | -$459.0K | -$456.0K | |
| Payments Of Stock Issuance Costs | $0.00 | $0.00 | $619.0K | $111.0K | $118.0K | $48.0K | $912.0K |
| Increase Decrease In Prepaid Expense | $914.0K | -$5.1M | -$2.3M | $447.0K | -$952.0K | ||
| Increase Decrease In Contract With Customer Liability | $0.00 | $0.00 | -$7.3M | -$813.0K | $5.4M | -$2.4M | |
| Proceeds From Issuance Of Common Stock | $104.7M | $100.0M | $75.0M | $50.0M | $50.4M | ||
| Increase Decrease In Research And Development Tax Credit Receivable | -$535.0K | -$4.2M | -$8.4M | $6.0M | $4.4M | ||
| Increase Decrease In Employee Related Liabilities | $2.9M | $6.6M | -$235.0K | $1.6M | $3.2M | ||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 5.7M | 2.7M | 929.0K | 399.0K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $102.0K | -$18.0K | $839.0K | -$1.2M | $351.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q1 2023 | Q3 2022 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $11.1M | $9.5M | $2.8M | $4.0M | $868.0K | $297.0K | ||||||
| Payments To Acquire Property Plant And Equipment | $422.0K | $4.0K | $53.0K | $361.0K | $39.0K | $30.0K | ||||||
| Net Cash Provided By Used In Operating Activities | -$61.2M | -$30.1M | -$13.1M | -$19.0M | -$20.7M | -$5.0M | ||||||
| Net Cash Provided By Used In Investing Activities | $160.1M | $19.9M | -$645.1M | -$361.0K | -$39.0K | -$194.0K | ||||||
| Net Cash Provided By Used In Financing Activities | $7.7M | $485.0K | $80.1M | $25.2M | $55.9M | $3.0K | ||||||
| Increase Decrease In Accounts Payable | $356.0K | $3.7M | $308.0K | $2.8M | -$2.1M | $2.7M | ||||||
| Increase Decrease In Accrued Liabilities | $1.6M | -$2.2M | $730.0K | -$832.0K | $2.0M | -$745.0K | ||||||
| Increase Decrease In Accounts Receivable | $0.00 | -$350.0K | -$455.0K | $114.0K | $1.2M | |||||||
| Stock Issued During Period Value Share Based Compensation | $2.0M | $2.2M | $7.7M | $1.6M | $212.0K | $485.0K | $229.0K | $651.0K | $108.0K | $187.0K | ||
| Increase Decrease In Operating Lease Liability | $25.0K | -$92.0K | -$367.0K | -$297.0K | -$152.0K | -$61.0K | ||||||
| Payments Of Stock Issuance Costs | $0.00 | $539.0K | $0.00 | |||||||||
| Increase Decrease In Prepaid Expense | $2.8M | -$331.0K | -$2.7M | -$1.6M | $472.0K | |||||||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$2.7M | -$1.2M | $1.7M | ||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $104.7M | $0.00 | |||||||||
| Increase Decrease In Research And Development Tax Credit Receivable | -$632.0K | -$850.0K | $1.7M | $3.7M | $1.6M | |||||||
| Increase Decrease In Employee Related Liabilities | -$7.6M | $606.0K | -$3.2M | -$3.5M | $141.0K | |||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 2.0M | 485.0K | 651.0K | 187.0K | 897.0K | |||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $38.0K | -$36.0K | $444.0K | -$166.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $-1.44 | $-0.31 | $-0.99 | $-0.41 | $-0.67 | $-0.76 | $-0.89 |
| Earnings Per Share Basic | $-1.44 | $-0.31 | $-0.99 | $-0.41 | $-0.67 | $-0.76 | $-0.89 |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Weighted Average Number Of Shares Outstanding Basic | 747.7M | 718.5M | 619.6M | 193.3M | 131.7M | 69.5M | 32.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 747.7M | 718.5M | 619.6M | 193.3M | 131.7M | 69.5M | 32.8M |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 350.0M | 250.0M | 250.0M |
| Common Stock Shares Outstanding | 775.4M | 737.6M | 701.7M | 211.1M | 98.0M | 82.6M | 67.2M |
| Common Stock Shares Issued | 775.4M | 737.6M | 701.7M | 211.1M | 98.0M | 82.6M | 67.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $-0.31 | $-0.76 | $-0.09 | $-0.08 | $-0.09 | $-0.06 | $-0.03 | $-0.02 | $-1.43 | $-0.10 | $-0.12 | $-0.15 | $-0.20 | $-0.27 | $-0.21 | $-0.26 | $-0.23 | $-0.09 | $-0.20 | |
| Earnings Per Share Basic | $-0.31 | $-0.76 | $-0.09 | $-0.08 | $-0.09 | $-0.06 | $-0.03 | $-0.02 | $-1.43 | $-0.10 | $-0.12 | $-0.15 | $-0.20 | $-0.27 | $-0.21 | $-0.26 | $-0.23 | $-0.09 | $-0.20 | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||
| Weighted Average Number Of Shares Outstanding Basic | 743.4M | 742.6M | 738.1M | 726.7M | 707.9M | 701.8M | 697.7M | 697.7M | 378.2M | 208.9M | 140.1M | 140.0M | 99.0M | 92.1M | 82.8M | 67.2M | 67.2M | 67.2M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 743.4M | 742.6M | 738.1M | 726.7M | 707.9M | 701.8M | 697.7M | 697.7M | 378.2M | 208.9M | 140.1M | 140.0M | 99.0M | 92.1M | 82.8M | 67.2M | 67.2M | 67.2M | ||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 350.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | ||||
| Common Stock Shares Outstanding | 744.4M | 742.8M | 741.6M | 737.1M | 724.3M | 702.0M | 697.9M | 697.7M | 697.7M | 201.3M | 98.1M | 98.1M | 97.6M | 97.4M | 82.9M | |||||
| Common Stock Shares Issued | 744.4M | 742.8M | 741.6M | 737.1M | 724.3M | 702.0M | 697.9M | 697.7M | 697.7M | 201.3M | 98.1M | 98.1M | 97.6M | 97.4M | 82.9M | 67.2M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $732.4M | $51.0M | $14.1M | $11.9M | $12.8M | $1.8M | $845.0K |
| Foreign Currency Transaction Gain Loss Unrealized | $320.0K | -$229.0K | $812.0K | -$2.6M | -$326.0K | $278.0K | -$423.0K |
| Depreciation | $146.0K | $89.0K | $198.0K | $349.0K | $330.0K | $302.0K | $321.0K |
| Additional Paid In Capital | $2.95B | $1.60B | $1.07B | $504.8M | $384.0M | $293.4M | $241.2M |
| Interest Paid Net | $0.00 | $8.8M | $10.7M | $434.0K | $85.0K | $0.00 | |
| Other Operating Income | $14.4M | $21.0M | $19.3M | $22.9M | |||
| Prepaid Expense Current | $2.4M | $1.5M | $7.2M | $9.5M | $8.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $130.8M | $478.8M | $11.1M | $19.4M | $11.1M | $9.5M | $705.0K | $1.9M | $2.8M | $2.8M | $2.5M | $4.0M | $2.6M | $3.7M | $868.0K | $361.0K | $530.0K | $297.0K | $244.0K |
| Foreign Currency Transaction Gain Loss Unrealized | $224.0K | -$9.0K | $470.0K | -$1.0M | $1.7M | -$75.0K | |||||||||||||
| Depreciation | $25.0K | $27.0K | $90.0K | $69.0K | $80.0K | $72.0K | |||||||||||||
| Additional Paid In Capital | $2.26B | $2.10B | $1.62B | $1.59B | $1.29B | $1.08B | $1.05B | $1.05B | $1.05B | $493.6M | $391.2M | $388.3M | $377.2M | $373.9M | $295.1M | $242.4M | |||
| Interest Paid Net | $0.00 | $1.5M | $1.3M | $0.00 | |||||||||||||||
| Other Operating Income | $584.0K | $5.5M | $3.0M | $4.8M | $4.8M | $6.1M | $5.4M | $4.3M | $3.8M | $6.8M | $6.3M | ||||||||
| Prepaid Expense Current | $5.1M | $6.1M | $1.2M | $1.6M | $5.4M | $4.4M | $8.4M | $5.7M | $8.0M | $7.1M |
Most recent annual filing with the SEC: February 23, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.